TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014
TCL Archive Excerpts From A Confidential Report Detailing the I-ELCAP Study’s Design Flaws and Lack of Consent April 29, 2011
TCL Archive The March: Cancer Centers To Plan Events In Conjunction With Sept. 26 March April 10, 1998
TCL Archive ACS Asks $1.5 Billion for NCI; Waxman Considers Requiring NIH To Send Budget Directly To Congress March 4, 1983